baber/WOPTO huggingface dataset:
Patent CA-2671365-A1 (CA)
Title: Use of dsm-2 gene as a selectable marker for selecting herbicidal resistant plants
Inventor: MERLO DONALD J
IPC: A01N57/20
Filed: 2007-12-07
Abstract: The subject invention relates to a novel gene referred to herein as DSM-2. This gene was identified in Sterptomyces coelicolor A3. The DSM-2 protein is distantly related to PAT and BAR. The subject invention also provides plant-optimized genes encoding DSM-2 proteins, DSM-2 can be used as a transgenic trait to impart tolerance in plants and plant cells to the herbicides glufosinate and bialaphos. One preferred use of the subject genes are as selectable markers. The use of this gene as a selectable marker in a bacterial system can increase efficiency for plant transformations. Use of DSM-2 as the sole selection marker eliminates the need for an additional medicinal antibiotic marker (such as ampicillin resistance) during cloning. Various other uses are also possible according to the subject invention.
Patent CA-2673040-A1 (CA)
Inventor: WEBER LUTZ
IPC: A61K31/4965
Filed: 2007-11-09
Abstract: The present invention relates to the use of a tri-substituted glycerol compound for the manufacture of a medicament for the treatment of hematological malignancies. The invention also refers to a kit-of-parts comprising such a medicament. Finally, the invention also relates to a corresponding method for the treatment of such conditions as well as to an in vitro method for determining the susceptibility of such malignant cells to a medicament as defined in the invention.
Patent CA-2673251-A1 (CA)
Inventor: MIYAKE TAKAMURA
IPC: A61M35/00
Filed: 2007-12-19
Abstract: Disclosed is an ultrasonic treatment apparatus which can achieve the treatment of a part of interest without the need of using any chemical substance. The apparatus comprises: a treatment vessel (11) for including a medium; an ultrasonic element for generating an ultrasonic wave in the treatment vessel (11), irradiating the medium contained in the treatment vessel (11) with the ultrasonic wave, and decomposing water contained in the medium to generate a hydroxy radical; an ultrasonic element-driving circuit for driving the ultrasonic element; and an operation unit (13) for setting a given conditions for sterilization determined based on the amount of the hydroxy radical generated upon the generation of the ultrasonic wave. Since the given conditions for sterilization determined based on the amount of the hydroxy radical generated upon the generation of the ultrasonic wave is set, the sterilizing effect can be remarkably improved.
Patent CA-2676209-A1 (CA)
Title: Hot or cold runner manifold
Inventor: GUENTHER HERBERT
IPC: B29C45/18
Filed: 2009-08-19
Abstract: The invention relates to a manifold 20 for a hot or cold runner 10 and fitted with a manifold plate 201 which comprises a main feed duct 24 for a flowable feed material and further contains a manifold duct system 40 having manifold ducts 42, 43, said system communicating flow-wise through nozzle feed ducts 26 with flow ducts 32 of injection molding nozzles 30 connected to said manifold plate 201.  Each manifold duct 42, 42, 43 communicates flow-wise with the main feed duct 24 and/or with at least one manifold feed duct 27, 271, 272, each manifold duct 41, 42, issuing into at least one manifold feed duct 27, 271, 272 and/or into at least one nozzle feed duct 26 and each manifold feed duct 27, 271, 272 issuing into a further manifold duct 41, 42, 43 and each nozzle feed duct 20 into the flow duct 32 of each associated injection molding nozzle 30. The manifold ducts 41, 42, 43, the manifold feed ducts 27, 271, 272 and/or the nozzle feed ducts 26 are dimensioned in a way to balance the manifold duct system. The nozzle feed ducts 26 may be arrayed in an n x m matrix, where n = m or n .noteq. m and n >= 3. The manifold ducts 41, 42, 43 may be situated in one plane and be horizontal. The manifold feed ducts 27, 271, 272, the nozzle feed ducts 26 and the main feed duct 24 may be vertical. The main feed duct 24 is mounted in a way that none of the nozzle feed ducts is situated directly below the main feed duct 24.
Patent CA-2676706-A1 (CA)
Inventor: SLOPER PETER
IPC: B60R9/048
Filed: 2008-01-31
Abstract: This invention provides a roof rack capable of realisably securing items to the exterior of a vehicle. The roof rack includes a frame for forming a partial enclosure, the frame being attachable to the vehicle; a retaining means pivotally movable within the frame from an open position, allowing access in and out of the frame to a closed position, where an item in the frame is retained, and an engaging and releasing means for releasably engaging the retaining means in the closed position. The advantages of the present invention include ease of use for releasably retaining at least one item to the roof of a vehicle; improved security of items to be retained, and improved safety of retaining items to the roof of a vehicle.
Patent CA-2677804-A1 (CA)
Inventor: WILLIAMS RICHARD B
IPC: C40B50/06
Filed: 2008-02-12
Abstract: Methods and compositions are provided for producing libraries of soluble random polypeptides. In the methods, the fraction of hydrophilic residues in the polypeptide is controlled so as to maintain the solubility of the polypeptide constructs.
Patent CA-2679030-A1 (CA)
Title: Alpha-2-delta ligand to treat lower urinary track symptoms
Inventor: WUSTROW DAVID JUERGEN
IPC: A61K31/195
Filed: 2003-12-03
Abstract: The invention relates to the use of a combination of an alpha-2-delta ligand with a compound selected from 
(i) a PDEV inhibitory compound; or 
(ii) a muscarinic antagonist;  
or pharmaceutically acceptable salts or solvates thereof, for the manufacture of a medicament for the treatment of LUTS associated with OAB and/or BPH.
Patent CA-2680771-A1 (CA)
Inventor: KOGEL BABETTE-YVONNE
IPC: A61K31/137
Filed: 2008-03-10
Abstract: L'invention concerne l'utilisation de composés de 1-phényl-3-diméthylamino-propane pour la fabrication de médicaments pour le traitement d'une douleur neuropathique, de manière préférée polyneuropathique, de manière plus préférée une douleur neuropathique diabétique, de manière préférée une douleur neuropathique périphérique diabétique, de manière plus préférée pour le traitement d'une neuropathie périphérique diabétique.
Patent CA-2680947-A1 (CA)
Inventor: GOURDREAS LEON
IPC: G05B19/00
Filed: 2008-04-04
Abstract: A combination of specific antenna type(s), with a system of specific antenna Rf field deployment, combined with the intelligent sensing of differing micro processor control of a digital antenna attenuator that controls disproportional attenuation (either synchronously or independently) of the transmission and reception areas of the antenna(e), of electronically paired devices, together with conditional time delays, is used to securely determine the ID and intent of an Rf access system user. A multifunctional remote device (condition unit) is carried by a carrier, the remote device transmits a short range radio frequency (Rf) signal which, when within range, is received by a stationary control unit. A second multifunctional remote device (cluster unit) is carried by the operator of the carrier and must be in secure communication with the condition unit to enable secure transmission between the control and the control unit. The operation of both said multifunctional remote units changes significantly with application in differing fields of use. By intelligently varying the interactive antenna Tx and Rx area, the proximity and therefore position of the remote (condition) unit to the base (control) unit can be deduced, outwardly appearing as a decoding of the intent of the carrier. This system can be implemented as a secure card-less RFID entry system for vehicle, building, border entry and mass transit systems.
Patent CA-2682202-A1 (CA)
Inventor: SEED BRIAN
IPC: A61P3/00
Filed: 2008-04-01
Abstract: Provided are compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by SGLT inhibition.
Patent CA-2684549-A1 (CA)
Inventor: REYAL JEAN-PIERRE
IPC: E04D13/18
Filed: 2008-04-18
Abstract: Structure (1) pour le montage dans une paroi d'un bâtiment, d'au moins un bâti (50) constitué d'un cadre rectangulaire (51), comprenant une armature (2) constituée d'au moins deux montants (3) et au moins deux traverses (4), assemblés de façon à former au moins un châssis rectangulaire (15) adapté po ur recevoir un bâti (50) et des moyens de fixation d'au moins un bâti sur l' armature, chaque montant (3) ayant une âme centrale (31) bordée par deux ail es latérales (32, 33) comportant des échancrures prévues pour recevoir les t raverses (4). Chaque traverse (4) a une âme centrale (40) et des ailes latér ales (41, 42) comportant des échancrures prévues pour venir au droit des mon tants (3) aux intersections entre les traverses (4) et les montants (3), de telle sorte que les ailes des montants (3) et des traverses (4), qui s'étend ent à la périphérie interne du châssis rectangulaire (15) forment une bordur e en saillie sur laquelle un bâti (50) peut venir s'emboîter. Paroi munie d' une telle structure sur laquelle sont montés des bâtis support de panneaux.
Patent CA-2685367-A1 (CA)
Inventor: SIMPSON MICHAEL J
IPC: A61F2/16
Filed: 2008-04-29
Abstract: An IOL (10) is disclosed that includes an anterior surface (14) and a posterior surface (16) disposed about an optical axis (OA), where the posterior surface includes a central region extending to a peripheral region (22). Once the IOL is implanted in a patient's eye, the anterior surface and the central region of the posterior surface cooperatively form an image of a field of view on the retina and the peripheral region of the posterior surfac directs at least some light rays (24a, 24b) incident thereon (e.g., via refraction by the anterior surface) to at least one retinal location offset from the image so as to inhibit dysphotopsia.
Patent CA-2686385-A1 (CA)
Inventor: BUETTELMANN BERND
IPC: C07D405/06
Filed: 2008-05-13
Abstract: Compounds of formula I or a pharmaceutically acceptable salt thereof are effective modulators of JNK: (formula) wherein X, Y, Z, R4, R5, R6 and R7 are as defined herein.
Patent CA-2688954-A1 (CA)
Inventor: NARDIN ALBERTO
IPC: A63H5/00
Filed: 2009-11-23
Abstract: A pop-up toy includes an housing with a lid and a handle operable by a player to release a pop-up doll within the housing. The pop up toy is a licensed character where rights in a copyright and/or trademark in the character are held by another party and licensed to the manufacturer to allow use of the character.  The handle also operates a sound generating system having a memory containing a plurality of sound tracks at least some of which are associated with the licensed character.
Patent CA-2689155-A1 (CA)
Inventor: KOPETZKI ERHARD
IPC: C12N5/10
Filed: 2008-06-25
Abstract: The current invention comprises a CHO cell which is expressing a constitutively active mitogenic receptor, a method of obtaining such a CHO cell, and a method for the expression of a heterologous polypeptide using a CHO cell according to the invention.
Patent CA-2690029-A1 (CA)
Inventor: KIELLAND PETER JOHANN
IPC: B25B21/00
Filed: 2010-01-18
Abstract: A bracket for magnetically holding a "Multi-Bit Dual-Mode Screwdriver For Either Manual Or Powered Actuation" onto an electric drill, said bracket comprised of: a length of U-shaped channel formed of magnetically attractable material and having a base portion, a left side portion and a right side portion, said left and right portions having a height above said base portion sufficient to receive the portion of the plastic handle of said screwdriver that protrudes from between two circumferentially adjacent bits and spaced apart such that said bits are magnetically held to said left and right bracket portions by the magnet force exerted by the bit-retention magnet embedded in said screwdriver's handle; and a double-sided adhesive strip which holds the base portion of said bracket onto said drill.
Patent CA-2690545-A1 (CA)
Title: Substituted bicyclic heteroaryl compounds and their use
Inventor: LAMPE THOMAS
IPC: C07D307/80
Filed: 2008-06-03
Abstract: The present application relates to novel substituted bicyclic heteroaryl compounds, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular diseases.
Patent CA-2691589-A1 (CA)
Inventor: BLACK PETER JOHN
IPC: H04L47/30
Filed: 2005-08-30
Abstract: Adaptive De-Jitter Buffer for Voice over IP (VoIP) for packet switch communications.  The de-jitter buffer methods and apparatus presented avoid playback of underflows while balancing end-to-end delay. In one example, the de-jitter buffer is recalculated at the beginning of each talkspurt. In another example, talkspurt packets are compressed upon receipt of all remaining packets.
Patent CA-2692969-A1 (CA)
Title: Electrical storage module having heat sinks
Inventor: RECHENBERG KARSTEN
IPC: H01G2/08
Filed: 2008-06-24
Abstract: The invention relates to, amongst other things, an electric memory module (100) provided with at least two capacitors (20, 30, 40) that are interconnected by an electrically conductive connection device. The memory module comprises an electric insulation which electrically insulates the memory module, and the memory module comprises a cooling body. According to the invention, the cooling body (110, 120) forms the connecting device and the electric insulation (150) is applied to the outside of said cooling body (110, 120).
Patent CA-2693529-A1 (CA)
Title: Split-cycle engine with a helical crossover passage
Inventor: TUSSING MARK
IPC: F02B33/22
Filed: 2008-06-11
Abstract: An engine has a crankshaft. A compression piston within a compression cylinder is connected to the crankshaft such that the compression piston reciprocates through an intake stroke and a compression stroke. An expansion piston within an expansion cylinder is connected to the crankshaft such that the expansion piston reciprocates through an expansion stroke and an exhaust stroke. A crossover passage interconnects the compression and expansion cylinders. The crossover passage includes a crossover compression valve and a crossover expansion valve. A runner section is in a downstream portion of the crossover passage, and a helical end section is integrally connected to the runner section. The helical end section has a funnel spiraling about a valve stem of the crossover expansion valve. The funnel forces incoming air to rotate about the valve stem prior to entering the expansion cylinder to promote turbulent kinetic energy in the cylinder air/fuel charge.
Patent CA-2694747-A1 (CA)
Inventor: ROBERTS NEIL JAMES
IPC: B25D17/11
Filed: 2008-07-14
Abstract: A system and method are described that facilitate bilateral private interaction between participants who wish to initiate personal or business arrangements anonymously or without exposure except to identified trusted parties=and the system and method act as an intermediary allowing the participants, typically buyers and sellers, to be matched based upon requests for and offers of goods and services, without revealing the identity or other identifying information about either the items or the participants until the participants choose to reveal that information
Patent CA-2695706-A1 (CA)
Inventor: BURGARD ANTHONY P
IPC: C12P7/18
Filed: 2008-08-06
Abstract: The invention provides a non- naturally occurring microorganism comprising one or more gene disruptions, the one or more gene disruptions occurring in genes encoding an enzyme obligatory to coupling 1,4-butanediol production to growth of the microorganism when the gene disruption reduces an activity of the enzyme, whereby theone or more gene disruptions confers stable growth-coupled production of 1,4-butanediol onto the non--naturally occurring microorganism. The microorganism can further comprise a gene encoding an enzyme in a 1,4- butanediol (BDO) biosynthetic pathway. The invention additionally relates to methods of using microorganisms to produce BDO.
Patent CA-2697122-A1 (CA)
Title: Method and system for identifying drawing primitives for selective transmission to a remote display
Inventor: BYFORD DUSTIN
IPC: G06F3/14
Filed: 2010-03-17
Abstract: Remote desktop servers include a display encoder that maintains a secondary framebuffer that contains display data to be encoded and transmitted to a remote client display and a list of display primitives effectuating updated display data in the secondary framebuffer. The display encoder submits requests to receive the list of drawing primitives to a video adapter driver that receives and tracks drawing primitives that, when executed, update a primary framebuffer.
Patent CA-2701719-A1 (CA)
Inventor: EDWARDS DAVID A
IPC: A61K35/74
Filed: 2008-10-06
Abstract: Methods and compositions of spray drying cellular material are provided that allow preservation of the cellular material. In one aspect, the cellular material is spray dried with a quantity of excipient. In another aspect, the cellular material is spray dried using a cryoprotectant.
Patent CA-2702586-A1 (CA)
Inventor: DELCAYRE ALAIN
IPC: A61K39/00
Filed: 2008-10-16
Abstract: The invention relates to compositions, kits, and methods for cancer prophylaxis and therapy using recombinant MVA viruses encoding tumor-associated antigens, such as PSA  and PAP. The recombinant MVA viruses can induce B- and T-cell responses.  The recombinant MVA viruses can be administered prior to, at the same time as, or after a taxane.
Patent CA-2702716-A1 (CA)
Inventor: LIVINGSTONE ELIZABETH L
IPC: A41C1/06
Filed: 2010-05-04
Abstract: A clothing article such as a leotard has a built-in bra that is connected with the article only along an upper edge. The bra is thus free-floating and provides improved fit, comfort, support and appearance to the wearer, particularly during dance movements.  The bra includes front and side wall portions which are connected with the leotard. The back wall portions of the bra contain an adjustable fastener and are free of the leotard so that the wearer can adjust the bra for proper fit of the bra and the leotard.
Patent CA-2702873-A1 (CA)
Inventor: PORSTMANN FRANK
IPC: C07C271/12
Filed: 2008-10-18
Abstract: The present invention relates to a process of preparing a compound of Formula I: (I) Formula I Wherein R1 is defined in the specification. Compounds of Formula I are useful for treating disorders of the central nervous system, including epilepsy.  The process includes a novel use of the reagent lithium borohydride.
Patent CA-2704389-A1 (CA)
Title: Transparent conductive oxide coating for thin film photovoltaic applications and methods of making the same
Inventor: CORDING CHRISTOPHER R
IPC: C03C17/34
Filed: 2008-11-03
Abstract: The present invention provides transparent conductive oxide (TCO) thin films with improved optical and electrical properties and methods of making the same. More specifically, the invention provides on-line processes for producing TCO thin films that allow for improvements in optical properties and post-production improvements in electrical properties of the TCO.
Patent CA-2705363-A1 (CA)
Title: Process of decoration of powder coated substrates
Inventor: MARELLI ERNESTO
IPC: C09D5/03
Filed: 2008-11-24
Abstract: The present invention is directed to process of decorating a powder coated substrate comprising the steps (a) treating a substrate surface to be coated, (b) applying a powder coating composition on the treated substrate surface and curing the powder coating composition, and (c) covering the cured powder coating with a support comprising a decoration, and transfer the decoration onto the coated substrate surface by heating, wherein a powder coating composition is used comprising (A) 30 to 80 wt% of a mixture of at least one polyester resin A having a hydroxyl number in the range of 30 to 60 mg KOH/g, a weight average molar mass Mn in a range of 3100 to 5000 and a glass transition temperature Tg of 40 to 60 °C and at least one polyester resin B having a hydroxyl number in the range of 250 to 350 mg KOH/g, a weight average molar mass Mn in a range of 2000 to 3000, (B) 10 to 40 wt% of at least one hardener selected from the group consisting of diisocyanates, polyisocyanates and urethdiones, and (C) 0,01 to 40 wt%  of at least one coating additive, pigment and/or filler, the wt% being based on the total weight of the powder coating composition, and wherein the transfer by heating is performed in a temperature range between 160 °C and 220 °C. The process provides a coated substrate surface with permanent decorations on it and additionally with a very good anti-graffiti performance for a long time period.
Patent CA-2709633-A1 (CA)
Title: Concurrency method for forecasting impact of speed tiers on consumption
Inventor: PACLIK JOHN
IPC: H04L12/26
Filed: 2010-07-09
Abstract: A forecast model processes performance data from a site, e.g., a cable modem termination system (CMTS), to obtain a set of concurrency equations for existing speed tiers that is based on an observed subscriber bandwidth for the site. A new set of concurrency equations is obtained for new speed tiers so that a new subscriber bandwidth can be predicted for the new speed tiers. Based on the new subscriber bandwidth, expected subscriber growth, and changes in data consumption, the site is reconfigured with additional ports based on the forecast. This process can be repeated for the other sites. Sites may be grouped together based on the observed subscriber bandwidth. A new subscriber bandwidth may be predicted for the group with the new speed tiers so that additional ports can be configured for each of the sites in the group.
Patent CA-2709994-A1 (CA)
Title: Non-antibody scaffold protein fusions phage display via fusion to pix of m13 phage
Inventor: JACOBS STEVEN
IPC: C40B40/02
Filed: 2008-12-19
Abstract: The invention relates to composi-tions and methods for generating and using p1X  phage display libraries for producing non-anti-body scaffold protein fusions using p1X of M13 phage.
Patent CA-2710323-A1 (CA)
Inventor: TORRES MARLENE H
IPC: F16L41/02
Filed: 2009-01-13
Abstract: A flow splitter that divides a two-phase (gas-liquid) inlet stream or a one-phase (liquid-liquid) inlet stream into equal and substantially balanced parts for distribution to an equal number of outlets horizontally oriented and connected to the flow splitter.  Because of the design of the flow splitter, no control instrumentation or retention time is required during a split. Openings in each face of the flow splitter help to equalize pressure in the split and allow liquid to fill an end chamber that supports impact forces on a wedge-shaped spreader oriented with its leading edge toward an inlet stream.
Patent CA-2711934-A1 (CA)
Inventor: FUKUYO SHOJI
IPC: C07B57/00
Filed: 2009-01-14
Abstract: Salts of optically active [4-(2-diphenylphosphanylnaphthalen-1-yl)phthalazin-1-yl]-(1-phenylethyl)amines represented by the formulas (1) to (4) with an optically active organic sulfonic acid, and a production method thereof.
Patent CA-2713377-A1 (CA)
Inventor: MOENS AN L
IPC: A61K31/519
Filed: 2009-02-06
Abstract: The present invention relates to the use of high dose of folic acid, or an equivalent dose one of its biological active derivatives to blunt myocardial dysfunction during ischemia and to ameliorate post-reperfusion injury. The invention specially re-lates to an early treatment by the application of a high dose of at least 200mg folic acid, or an equivalent dose of a derivative dur-ing active ischemia, before the reperfusion.